4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-17-000062
$JAZZCIK 0001232524operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:56 PM ET
Size
7.7 KB
Accession
0001232524-17-000062
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Award
Ordinary Shares
2017-03-02+4,500→ 18,463 total - Award
Non-Qualified Stock Option (right to buy)
2017-03-02+11,250→ 11,250 totalExercise: $136.18Exp: 2027-03-01→ Ordinary Shares (11,250 underlying)
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]Includes 93 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016.
- [F3]These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:56 PM ET
- Size
- 7.7 KB